equityflowunderstand the flow and follow it

osapiens

Climate · Mannheim, DE · osapiens.com

osapiens HUB SaaS platform for ESG compliance, supply chain and sustainability reporting for large enterprises.

Founders

Alberto Zamora (Spain · ♂) — He co-founded osapiens in Mannheim in 2018 to build a platform delivering supply-chain transparency and automated sustainability reporting for companies.
Stefan Wawrzinek (Germany · ♂) — A co-founder of osapiens, he helped build the sustainability and supply-chain transparency software that grew into a German unicorn.
Matthias Jungblut (Germany · ♂) — A co-founder of osapiens, he contributed to building the company's technology platform for sustainability and supply-chain compliance.
Patrick Lanz
Tobias Schlereth

Team & hubs

People & leadership

Patrick Lanz Co-Founder osapiens terraMatthias Jungblut Co-Founder | Co-CEO at osapiensAlberto Zamora Co-founder & Co-CEO at osapiensStefan Wawrzinek Co-Founder & Chairman at osapiensTobias Schlereth Operations Efficiency | Co-Founder at osapiens AssetOps GmbH

Funding history

Date	Round	Amount
Jan 2026	Series C Germany's osapiens closed a $100 million Series C led by Decarbonization Partners, becoming a sustainability software unicorn.	$100M
Jul 2024	Growth Mannheim supply-chain software firm osapiens raised 120M USD led by Goldman Sachs.	$120M
Sep 2023	Growth Mannheim supply-chain software firm osapiens raised EUR 25M from Armira Growth.	$27M

Investors

Tap an investor to see what else they have backed.

Armira Growth Decarbonization Partners Goldman Sachs Alternatives

Acquisitions

osapiens has acquired Lucent AI.

Other companies in Climate

Skyfora Resand GR3N D-CRBN Mykor Borro Circular11 DEScycle Seenons Climeworks FieldFactors CuspAI

Other companies in DE

NEURA Robotics Isar Aerospace GALVANY Pacifico Biolabs allO encosa Bayshore INXM NanoStruct Omnisent Proxima Fusion Peec AI

Other companies at Series C stage

99 Group 9fin A5X ACROVE AI21 Labs AMI ATAI Life Sciences Acceldata AccountsIQ ActiveCampaign Agicap AgomAb Therapeutics

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.